TCR2 Therapeutics Inc.
TCRRDelisted Jun 1, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001750019
TCR2 Therapeutics Inc. was delisted on Jun 1, 2023; its insiders filed their last Form 4 on Feb 14, 2024; 59 institutions reported holding it in 13F filings for Q1 2023, worth $31.5M in total; no superinvestor held it.
13F holders, Q3 2021
Institutional positions in TCR2 Therapeutics Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 117
- −2 vs. Q2 2021
- Shares held
- 31.8M
- −3.22M (−9.2%) vs. Q2 2021
- Total value
- $271.1M
- −$304.2M (−52.9%) vs. Q2 2021
- New holders
- 18
- 41 more added
- Sold out
- 20
- 35 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCRR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 59 | $31.5M |
| Q4 2022 | 63 | $21.2M |
| Q3 2022 | 81 | $45.1M |
| Q2 2022 | 83 | $72.2M |
| Q1 2022 | 94 | $74.8M |
| Q4 2021 | 122 | $136.0M |
| Q3 2021 | 117 | $271.1M |
| Q2 2021 | 119 | $575.3M |
| Q1 2021 | 129 | $834.8M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding TCR2 Therapeutics Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rothschild & Co Asset Management US Inc. | 348,395 | $2.96M | 0.04% | −341,879−49.5% | Reduced |
| Citadel Advisors LLC | 375,009 | $3.19M | 0.00% | −4,987−1.3% | Reduced |
| Geode Capital Management, LLC | 454,333 | $3.87M | 0.00% | −37,503−7.6% | Reduced |
| Ghost Tree Capital, LLC | 477,323 | $4.06M | 1.34% | +477,323 | New |
| Cormorant Asset Management, LP | 479,506 | $4.08M | 0.17% | 00.0% | Unchanged |
| Marshall Wace North America L.P. | 543,582 | $4.63M | 0.02% | +543,582 | New |
| First Light Asset Management, LLC | 620,887 | $5.28M | 0.35% | −23,329−3.6% | Reduced |
| Artal Group S.A. | 750,000 | $6.38M | 0.16% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,030,360 | $8.77M | 0.00% | +370,949+56.3% | Added |
| ArrowMark Colorado Holdings LLC | 1,213,498 | $10.3M | 0.08% | +186,370+18.1% | Added |
| Vanguard Group Inc | 1,454,072 | $12.4M | 0.00% | +64,712+4.7% | Added |
| State Street Corp | 1,514,717 | $12.9M | 0.00% | −716,507−32.1% | Reduced |
| Wellington Management Group LLP | 2,745,176 | $23.4M | 0.00% | −2,589,162−48.5% | Reduced |
| BlackRock Inc. | 2,964,645 | $25.2M | 0.00% | +27,527+0.9% | Added |
| MPM Oncology Impact Management LP | 3,370,982 | $28.7M | 4.45% | 00.0% | Unchanged |
| Redmile Group, LLC | 3,816,709 | $32.5M | 0.57% | +580,900+18.0% | Added |
| MPM Asset Management LLC | 4,050,865 | $34.5M | 7.99% | 00.0% | Unchanged |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −934,551−100.0% | Sold out |
| Sofinnova Investments, Inc. | 0 | $0 | 0.00% | −296,282−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −188,142−100.0% | Sold out |
| Moody Aldrich Partners LLC | 0 | $0 | 0.00% | −124,062−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −99,004−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −88,934−100.0% | Sold out |
| GAM Holding AG | 0 | $0 | 0.00% | −58,343−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −55,350−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −47,537−100.0% | Sold out |
| Teachers Retirement System of the State of Kentucky | 0 | $0 | 0.00% | −46,673−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −30,753−100.0% | Sold out |
| Copernicus Capital Management, LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Granite Point Capital Management, L.P. | 0 | $0 | 0.00% | −24,000−100.0% | Sold out |
| Glenmede Trust Co NA | 0 | $0 | 0.00% | −16,095−100.0% | Sold out |
| Alpha Paradigm Partners, LLC | 0 | $0 | 0.00% | −15,341−100.0% | Sold out |
| Virginia Retirement Systems Et Al | 0 | $0 | 0.00% | −13,900−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −13,554−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −2,608−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| Founders Capital Management | 0 | $0 | 0.00% | −100−100.0% | Sold out |